| Volume 19 • Issue 12 |
June 12, 2019 |
|
|
|
|
 |
| |
PrEUCRISATM - NOW AVAILABLE TO ORDER
|
|
|
Pfizer Canada is pleased to announce the launch and availability of PrEUCRISATM (crisaborole ointment 2%). EUCRISA is available in 60 gram tubes. To access EUCRISA Patient Information,
CLICK HERE
|
|
|
|
 |
| |
INTRODUCING SANDOZ HYDROCORTISONE 2.5%, A TOPICAL CORTICOSTEROID CREAM OPTION FOR PATIENTS
|
|
|
Remember - Hydrocortisone 2.5% is now provided by Sandoz.
LEARN MORE
|
 |
|
|
 |
| |
NEW – ORILISSA 200 MG BID AVAILABLE IN CANADA
|
|
|
AbbVie is proud to announce that PrORILISSATM is now available in two convenient oral strengths, providing you dosing flexibility: 150 mg QD & 200 mg BID.
To view ordering information,
CLICK HERE
|
 |
|
|
|
|
| |
CLINICALLY PROVEN EFFICACY OF VOLTAREN EMULGEL - NOW AVAILABLE WITH A NEW NOMESS APPLICATOR
|
|
|
Voltaren Emulgel with NoMess Applicator allows patients to apply Voltaren Emulgel directly onto the site of pain without getting gel on their hands. Now patients can get the clinically proven efficacy of Voltaren Emulgel while keeping their hands clean.
READ MORE
|
 |
|
| |
NATURALLY SOURCED COLD SORE TREATMENT
|
|
|
Speeds healing of cold sores by an average of…
READ MORE
|
 |
|
|
|
|
